For families and patients wanting more information about Allo Phase 2 Alzheimer’s Clinical Trial: LEARN MORE

Troubled by hot flashes? Learn more about the HF Relief Study being conducted at the University of Arizona to test the effectiveness of a natural product, PhytoSERM, to alleviate hot flashes:

For information about the PhytoSERM Brain Clinical Trial: LEARN MORE

Why is Alzheimer’s so complicated?

The Atlantic magazine features Dr. Roberta Diaz Brinton, her research journey, and why today’s Alzheimer’s research is moving from a one-size-fits-all approach to more personalized medicine strategies. The University of Arizona Center for Innovation in Brain Scienis working to develop the first regenerative therapeutic for a disease that is expected to affect more than 7.7 million people by 2030.

The Atlantic:Rethink – Alzheimer’s is More Complicated Than We Thought

The Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.

© 2024 Center for Innovation Brain Science. University of Arizona Health Sciences.

Skip to content